These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31268394)

  • 1. Emerging infectious disease laboratory and diagnostic preparedness to accelerate vaccine development.
    Roberts CC
    Hum Vaccin Immunother; 2019; 15(10):2258-2263. PubMed ID: 31268394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus.
    Maslow JN
    Hum Vaccin Immunother; 2017 Dec; 13(12):2918-2930. PubMed ID: 28846484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine development for emerging virulent infectious diseases.
    Maslow JN
    Vaccine; 2017 Oct; 35(41):5437-5443. PubMed ID: 28216184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assay Challenges for Emerging Infectious Diseases: The Zika Experience.
    Roberts CC; Maslow JN
    Vaccines (Basel); 2018 Oct; 6(4):. PubMed ID: 30279372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Funding vaccines for emerging infectious diseases.
    Wong G; Qiu X
    Hum Vaccin Immunother; 2018 Jul; 14(7):1760-1762. PubMed ID: 29194012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid response to an emerging infectious disease - Lessons learned from development of a synthetic DNA vaccine targeting Zika virus.
    Kudchodkar SB; Choi H; Reuschel EL; Esquivel R; Jin-Ah Kwon J; Jeong M; Maslow JN; Reed CC; White S; Kim JJ; Kobinger GP; Tebas P; Weiner DB; Muthumani K
    Microbes Infect; 2018 Dec; 20(11-12):676-684. PubMed ID: 29555345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology.
    Gilbert SC; Warimwe GM
    Vaccine; 2017 Aug; 35(35 Pt A):4461-4464. PubMed ID: 28576573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zika Virus Vaccine Development: Progress in the Face of New Challenges.
    Diamond MS; Ledgerwood JE; Pierson TC
    Annu Rev Med; 2019 Jan; 70():121-135. PubMed ID: 30388054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MERS coronavirus outbreak: Implications for emerging viral infections.
    Al-Omari A; Rabaan AA; Salih S; Al-Tawfiq JA; Memish ZA
    Diagn Microbiol Infect Dis; 2019 Mar; 93(3):265-285. PubMed ID: 30413355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus.
    Wirblich C; Coleman CM; Kurup D; Abraham TS; Bernbaum JG; Jahrling PB; Hensley LE; Johnson RF; Frieman MB; Schnell MJ
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral Emerging Diseases: Challenges in Developing Vaccination Strategies.
    Trovato M; Sartorius R; D'Apice L; Manco R; De Berardinis P
    Front Immunol; 2020; 11():2130. PubMed ID: 33013898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Glimmer of Hope: Recent Updates and Future Challenges in Zika Vaccine Development.
    Castanha PMS; Marques ETA
    Viruses; 2020 Nov; 12(12):. PubMed ID: 33266129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious diseases epidemic threats and mass gatherings: refocusing global attention on the continuing spread of the Middle East Respiratory syndrome coronavirus (MERS-CoV).
    Zumla A; Alagaili AN; Cotten M; Azhar EI
    BMC Med; 2016 Sep; 14(1):132. PubMed ID: 27604081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Zika Virus Vaccines.
    Garg H; Mehmetoglu-Gurbuz T; Joshi A
    Viruses; 2018 Nov; 10(11):. PubMed ID: 30441757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges of Vaccine Development for Zika Virus.
    Blackman MA; Kim IJ; Lin JS; Thomas SJ
    Viral Immunol; 2018 Mar; 31(2):117-123. PubMed ID: 29227202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Another emerging arbovirus, another emerging vaccine: Targeting Zika virus.
    Palacios R; Poland GA; Kalil J
    Vaccine; 2016 Apr; 34(20):2291-3. PubMed ID: 27015734
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
    Garg H; Sedano M; Plata G; Punke EB; Joshi A
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting Emerging Infectious Diseases: An Overview of the Laboratory Response Network for Biological Threats.
    Villanueva J; Schweitzer B; Odle M; Aden T
    Public Health Rep; 2019; 134(2_suppl):16S-21S. PubMed ID: 31682559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges.
    Cho H; Excler JL; Kim JH; Yoon IK
    Hum Vaccin Immunother; 2018 Feb; 14(2):304-313. PubMed ID: 29048984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates.
    Vannice KS; Cassetti MC; Eisinger RW; Hombach J; Knezevic I; Marston HD; Wilder-Smith A; Cavaleri M; Krause PR
    Vaccine; 2019 Feb; 37(6):863-868. PubMed ID: 30639461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.